Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under ...

GLP-1 drugs may result in better outcomes for cancer patients, study claims - GLP-1 drugs, such as Ozempic and Wegovy, may ...

Several studies have served up tantalizing hints about the drugs’ potential cancer prevention benefits, but other results land all over the map.

As demand for GLP-1 weight loss drugs skyrockets, so does the risk of getting scammed. What we've been seeing in our scam tracker is advertisements about supplements that work just as well as *** ...

Novo Nordisk, the pharmaceutical company behind Ozempic, has received a warning letter from the U.S. Food and Drug Administration over issues with its procedures for reporting potential side effects ...

The magic weight-loss pill everyone is talking about may come with a big drawback. That’s what Brianna Chickenfry believes about Ozempic. The weekly injectable medication is designed to treat type 2 ...

The U.S. Food and Drug Administration sent a warning letter this month to Novo Nordisk, the maker of Ozempic and Wegovy, alleging the drugmaker failed to report potential side effects in patients who ...